Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 84.97% is 103% above its 5-year average of -2448.20%, near the high end of its 5-year range (-31866.67%–96.58%).
32.28% above its 12-month average of 64.23%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 91.44%.
GROSS MARGIN
84.97%
GROSS MARGIN AVG TTM
64.23%
GROSS MARGIN AVG 3Y
-5867.53%
GROSS MARGIN AVG 5Y
-2448.20%
GROSS MARGIN AVG 10Y
-553.02%
GROSS MARGIN AVG 15Y
-196.93%
GROSS MARGIN AVG 20Y
-79.76%
CURRENT VS TTM AVG
+32.28%
CURRENT VS 3Y AVG
+101.45%
CURRENT VS 5Y AVG
+103.47%
CURRENT VS 10Y AVG
+115.36%
CURRENT VS 15Y AVG
+143.15%
CURRENT VS 20Y AVG
+206.53%
SECTOR MEDIAN · HEALTHCARE
39.94%
median of 690 covered companies
CURRENT VS SECTOR MEDIAN
+112.74%
vs the sector median at left
Cytokinetics, Incorporated
Market Cap
$7.70B
Gross Margin
84.97%
TTM Avg
64.23%
3Y Avg
-5867.53%
5Y Avg
-2448.20%
Market Cap
$7.55B
Gross Margin
84.52%
TTM Avg
78.41%
3Y Avg
74.39%
5Y Avg
74.39%
Market Cap
$7.92B
Gross Margin
0.00%
TTM Avg
-840.99%
3Y Avg
-1281.95%
5Y Avg
-854.63%
Market Cap
$8.02B
Gross Margin
69.66%
TTM Avg
54.89%
3Y Avg
42.48%
5Y Avg
46.51%
Market Cap
$7.37B
Gross Margin
98.16%
TTM Avg
98.36%
3Y Avg
98.29%
5Y Avg
98.36%
Market Cap
$8.44B
Gross Margin
14.38%
TTM Avg
17.24%
3Y Avg
38.82%
5Y Avg
59.22%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cytokinetics, Incorporated (CYTK) | $7.70B | 84.97% | 64.23% | -5867.53% | -2448.20% |
| HealthEquity, Inc. (HQY)vs › | $7.66B | 75.21% | 63.63% | 56.54% | 52.91% |
| Hinge Health, Inc. (HNGE)vs › | $7.55B | 84.52% | 78.41% | 74.39% | 74.39% |
| Praxis Precision Medicines, Inc. (PRAX)vs › | $7.92B | 0.00% | -840.99% | -1281.95% | -854.63% |
| Caris Life Sciences, Inc. (CAI)vs › | $8.02B | 69.66% | 54.89% | 42.48% | 46.51% |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.37B | 98.16% | 98.36% | 98.29% | 98.36% |
| Alkermes plc (ALKS)vs › | $7.13B | 84.56% | 85.47% | 84.03% | 83.69% |
| Oscar Health, Inc. (OSCR)vs › | $8.44B | 14.38% | 17.24% | 38.82% | 59.22% |
| Immunovant, Inc. (IMVT)vs › | $6.75B | 0.00% | 0.00% | 0.00% | 0.00% |
| Chemed Corporation (CHE)vs › | $6.68B | 30.44% | 32.55% | 34.06% | 34.32% |
Gross Margin
85.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 91.44% |
| 2026-03-31 | 87.64% |
| 2025-12-31 | 83.89% |
| 2025-09-30 | -38.38% |
| 2025-06-30 | 96.58% |
| 2025-03-31 | -6223.05% |
| 2024-12-31 | -453.13% |
| 2024-09-30 | -18174.73% |
| 2024-06-30 | -31866.67% |
| 2024-03-31 | -9668.86% |
| 2023-12-31 | -4982.30% |
| 2023-09-30 | -21733.86% |
| 2023-06-30 | -9495.62% |
| 2023-03-31 | -1621.68% |
| 2022-12-31 | -3733.32% |
| 2022-09-30 | -2394.39% |
| 2022-06-30 | 35.79% |
| 2022-03-31 | -3901.31% |
| 2021-12-31 | 21.77% |
| 2021-09-30 | -790.86% |
| 2021-06-30 | -1181.85% |
| 2021-03-31 | -381.99% |
| 2020-12-31 | -334.71% |
| 2020-09-30 | 41.94% |
| 2020-06-30 | -506.46% |
| 2020-03-31 | -468.31% |
| 2019-12-31 | -251.77% |
| 2019-09-30 | -234.09% |
| 2019-06-30 | -236.51% |
| 2019-03-31 | -178.18% |
| 2018-12-31 | -148.24% |
| 2018-09-30 | -101.02% |
| 2018-06-30 | -247.26% |
| 2018-03-31 | -320.18% |
| 2017-12-31 | 145938.89% |
| 2017-09-30 | -303.67% |
| 2017-06-30 | -548.84% |
| 2017-03-31 | -364.46% |
| 2016-12-31 | 29.76% |
| 2016-09-30 | 69.74% |
| 2016-06-30 | -67.58% |
| 2016-03-31 | -60.72% |
| 2015-12-31 | -35.79% |
| 2015-09-30 | -45.46% |
| 2015-06-30 | -93.15% |
| 2015-03-31 | -102.90% |
| 2014-12-31 | 59.65% |
| 2014-09-30 | -21.30% |
| 2014-06-30 | -50.71% |
| 2014-03-31 | -56.54% |
| 2013-12-31 | 43.23% |
| 2013-09-30 | -200.85% |
| 2013-06-30 | -1123.69% |
| 2013-03-31 | -1097.81% |
| 2012-12-31 | -351.37% |
| 2012-09-30 | -413.30% |
| 2012-06-30 | 100.00% |
| 2012-03-31 | 100.00% |
| 2011-12-31 | 100.00% |
| 2011-09-30 | 100.00% |
| 2011-06-30 | 100.00% |
| 2011-03-31 | 100.00% |
| 2010-12-31 | 100.00% |
| 2010-09-30 | 100.00% |
| 2010-06-30 | 100.00% |
| 2010-03-31 | 100.00% |
| 2009-12-31 | 100.00% |
| 2009-09-30 | 100.00% |
| 2009-06-30 | 100.00% |
| 2009-03-31 | 100.00% |
| 2008-12-31 | 100.00% |
| 2008-09-30 | 100.00% |
| 2008-06-30 | 100.00% |
| 2008-03-31 | 100.00% |
| 2007-12-31 | 100.00% |
| 2007-09-30 | 100.00% |
| 2007-06-30 | 100.00% |
| 2007-03-31 | 100.00% |
| 2006-12-31 | 100.00% |
| 2006-09-30 | 100.00% |
| 2006-06-30 | 100.00% |
| 2006-03-31 | 100.00% |
| 2005-12-31 | 100.00% |
| 2005-09-30 | 100.00% |
| 2005-06-30 | 100.00% |
| 2005-03-31 | 100.00% |
| 2004-12-31 | 100.00% |
| 2004-09-30 | 100.00% |
| 2004-06-30 | 100.00% |
| 2004-03-31 | 100.00% |
| 2003-12-31 | 100.00% |
| 2003-09-30 | 100.00% |
| 2003-06-30 | 100.00% |
| 2003-03-31 | 100.00% |
